USA |PINK |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||1.42%||Ex-Dividend Date|
|Held by Institutions||16.92%||IPO Date||-|
|Dec 21||Dec 20||Dec 19|
|Dec 21||Sep 21||Jun 21|
Orphazyme a/s trades on the OTC Markets stock market in USA under the ticker symbol "OZYMF". Orphazyme a/s’s stock symbol can also be displayed as "OTCMKTS:OZYMF".
Orphazyme a/s (OTCMKTS:OZYMF) is owned by 16.92% institutional shareholders and by 1.42% insiders. The rest is owned by the public.
Explore More Details on Orphazyme a/s's “Ownership” Section
Orphazyme a/s's key executive team includes the following managers:
Orphazyme a/s (OTCMKTS:OZYMF) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Orphazyme a/s is 62.
Orphazyme a/s (OTCMKTS:OZYMF) is headquartered in Denmark.
Orphazyme a/s’s mailing address is Ole MaalOees Vej 3, Copenhagen, Denmark, 2200.
The company’s phone number is 45 39 17 82 72.